These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 38030989)
1. Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome. Wang F; Cui S; Lu L; Shao X; Yan F; Liu Y; He B; Wang J; Cao Y; Yue Y; Wang Y; Gu W BMC Cancer; 2023 Nov; 23(1):1165. PubMed ID: 38030989 [TBL] [Abstract][Full Text] [Related]
2. Metabolic tumour area: a novel prognostic indicator based on Cui S; Xin W; Wang F; Shao X; Shao X; Niu R; Zhang F; Shi Y; Liu B; Gu W; Wang Y BMC Cancer; 2024 Jul; 24(1):895. PubMed ID: 39054508 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of Dmax and %ΔSUVmax of Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837 [TBL] [Abstract][Full Text] [Related]
4. Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT Cottereau AS; Meignan M; Nioche C; Capobianco N; Clerc J; Chartier L; Vercellino L; Casasnovas O; Thieblemont C; Buvat I Ann Oncol; 2021 Mar; 32(3):404-411. PubMed ID: 33278600 [TBL] [Abstract][Full Text] [Related]
5. [ Xu HQ; Song LJ; Ding CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic tumour volume on baseline Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463 [TBL] [Abstract][Full Text] [Related]
7. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [ Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of metabolic tumor volume and lesion dissemination from baseline PET/CT in patients with diffuse large B-cell lymphoma: Further risk stratification of the group with low-risk and high-risk NCCN-IPI. Xu H; Ma J; Yang G; Xiao S; Li W; Sun Y; Sun Y; Wang Z; Zhao H Eur J Radiol; 2023 Jun; 163():110798. PubMed ID: 37030099 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336 [TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT Maximum Tumor Dissemination to Predict Recurrence in Patients with Diffuse Large B-Cell Lymphoma. Jo JH; Chung HW; Kim SY; Lee MH; So Y Nucl Med Mol Imaging; 2023 Feb; 57(1):26-33. PubMed ID: 36643943 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline Delaby G; Hubaut MA; Morschhauser F; Besson A; Huglo D; Herbaux C; Baillet C Leuk Lymphoma; 2020 Jul; 61(7):1584-1591. PubMed ID: 32100597 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
13. [Prognostic significance of (18)F-fluorodeoxyglucose positron emission tomography in patients with diffuse large B cell lymphoma undergoing autologous stem cell transplantation]. Ying ZT; Mi L; Wang XJ; Zhang YW; Yang Z; Song YQ; Wang XP; Zheng W; Lin NJ; Tu MF; Xie Y; Ping LY; Zhang C; Liu WP; Deng LJ; Zhu J Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):382-386. PubMed ID: 29779346 [No Abstract] [Full Text] [Related]
14. Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment. Jin H; Jin M; Lim CH; Choi JY; Kim SJ; Lee KH Front Oncol; 2023; 13():1186311. PubMed ID: 37384292 [TBL] [Abstract][Full Text] [Related]
15. [Values of Different Evaluation Criteria of Interim Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288 [TBL] [Abstract][Full Text] [Related]
16. Value of Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma]. Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579 [No Abstract] [Full Text] [Related]
18. Predictive value of baseline Zhu L; Meng Y; Guo L; Zhao H; Shi Y; Li S; Wang A; Zhang X; Shi J; Zhu J; Xu K Oncol Lett; 2021 Feb; 21(2):132. PubMed ID: 33552253 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of 18F-FDG lesion dissemination features in patients with peripheral T-cell lymphoma (PTCL). Xie Y; Teng Y; Jiang C; Ding C; Zhou Z Jpn J Radiol; 2023 Jul; 41(7):777-786. PubMed ID: 36752954 [TBL] [Abstract][Full Text] [Related]